Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

GlaxoSmithKline presents bromodomain inhibitors

Oct. 5, 2016

TAK1 is a promising new target for osteoarthritis

Oct. 5, 2016

Coherus Biosciences regains rights for CHS-0214 from Shire

Sep. 28, 2016

FDA approves adalimumab biosimilar Amjevita

Sep. 26, 2016

Janssen Biotech submits BLA to the FDA for sirukumab

Sep. 26, 2016

Merck & Co. discloses IRAK-4 inhibitors

Sep. 26, 2016

GlaxoSmithKline prepares and tests bromodomain-containing protein inhibitors

Sep. 23, 2016

Daiichi Sankyo seeks Japanese approval for Pralia in rheumatoid arthritis

Sep. 23, 2016

Regen BioPharma's NR2F6 modulators show positive preclinical results

Sep. 22, 2016

Follistatin gene therapy receives FDA orphan designation for inclusion body myositis

Sep. 21, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...